glp-1 long term risks Application of nutrition interventions with based therapies: A narrative review of the challenges and solutions Assessing the Benefits, Risks, and

Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression

Ozempic activates the GLP-1 receptors, which results in the promotion of insulin production, suppression of glucagon secretion (a hormone that elevates blood sugar levels), deceleration of gastric emptying, and appetite reduction

Many people have seen meaningful progress and improvements in their health, while others have faced real challenges

These symptoms often appear when starting the program or increasing the dose, then improve as the body adjusts over time

50% [6]